Name: Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024
Start: 2024-10-18T08:00:00+02:00
End: 2024-10-19T23:30:00+02:00
Location: Zoom

Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024

from Friday, October 18, 2024 (8:00 AM) to Saturday, October 19, 2024 (11:30 PM)

Monday, October 14, 2024
Tuesday, October 15, 2024
Wednesday, October 16, 2024
Thursday, October 17, 2024
Friday, October 18, 2024
8:00 AM
8:00 AM - 11:30 AM
Contributions

8:00 AM Participants registration

8:45 AM Welcome Addresses

9:15 AM Historic and scientific evolution of Hadron Therapy - Ugo Amaldi (TERA Foundation (IT)) Sandro Rossi (CNAO)

9:35 AM Hadron Therapy in clinical practice - Sara Lillo (CNAO)

9:55 AM Radiobiology of Hadron Therapy - Angelica Facoetti (CNAO)

10:15 AM HITRIplus project, its impact on boosting research in South East Europe and future perspectives - Sanja Damjanovic (SEEIIST Association (CH) / GSI)

10:35 AM Building capacity through the IAEA programs - Sotirios Charisopoulos (IAEA)
11:30 AM
11:30 AM - 3:00 PM
Contributions

11:30 AM Hadron Therapy : from pioneering times towards the future - Manjit Dosanjh (University of Oxford (GB))

11:50 AM SEEIIST facility design and alternatives - Maurizio Vretenar (CERN)

12:10 PM CERN as an example of large scale infrastructure - Emmanuel Tsesmelis (CERN)

12:30 PM Status and vision of the SEEIIST project - Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))

12:50 PM Concluding remarks - Roberto Orecchia (IEO)

1:00 PM Round table – SEEIIST towards to the Future
3:00 PM SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
3:00 PM - 5:00 PM
Contributions

3:00 PM Hadron Therapy at GSI - where we come from, where we go - Konrad Lehmann (GSI)

3:25 PM The HIT facility, technology, clinical applications and research: novel approaches in particle therapy - Andrea Mairani (HIT)

3:50 PM The Krakow Hadron Therapy facility, lessons learnt - Pawel Olko (IFJ - PAN)

4:15 PM Concluding remarks - Angelica Facoetti (CNAO)
5:00 PM SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
5:00 PM - 10:20 PM
Contributions

5:00 PM Accelerator and beam physics developments for medical and societal applications at CERN - Alessandra Lombardi (CERN)

5:20 PM Innovative gantry designs: Superconducting magnets for advanced gantry - Ernesto De Matteis (INFN)

5:35 PM Innovative gantry designs-continued - Ariel Haziot (CERN)

5:50 PM Optimisation for pre-injectors for hadron therapy-AM - Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)

6:10 PM An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina - Amer Ajanovic (CERN/UNSA) Danis Bradaric (UNSA) Medina Dugonjic (UNSA) Naida Ustavdic (UNSA)

6:25 PM Development of the first table-top X-ray FLASH system - ELPIDA THEODORIDOU (DKFZ / Uni Malta) Joao Seco (DKFZ)

6:40 PM Concluding remarks - Laura Vallow (Mayo Clinic)

8:00 PM Welcome, Music event and Welcome Drink
Saturday, October 19, 2024
9:00 AM Indications and clinical applications of HT
Indications and clinical applications of HT
9:00 AM - 11:30 AM
Contributions

9:00 AM Chordoma treatments at CNAO - Maria Rosaria Fiore (CNAO)

9:25 AM Sarcoma treatments in Greece - Tasos Kyriazoglou (Attikon University Hospital)

9:45 AM Radiosurgery for Skullbase Meningiom - Christos Boskos (ST. LUKE'S)

10:05 AM SRS Treatment Planning for Endocranial Tumor - Anna Makridou

10:25 AM Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability - Michael Story (Mayo Clinic)

10:50 AM Concluding remarks - Arnold Pompos (UT Southwestern, Dallas, TX) Joao Seco (DKFZ)
11:30 AM SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
11:30 AM - 3:00 PM
Contributions

11:30 AM Hadrontherapy and EU clinical networks: status and perspectives - Lisa Licitra (CNAO, Uni Milan)

11:50 AM Costs of hadrontherapy, the ABC analysis applied to operations in CNAO - Maria Vittoria Livraga (CNAO)

12:10 PM Caring for cancer patients: the CNAO social approach - Silvia Meneghello (CNAO)

12:30 PM The role of citizens in innovating health - Katerina Zourou (Web2Learn) Stefania Oikonomou (Web2Learn)

12:45 PM The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level - Alkinoos Athanasiou (AUTH, ELEVIT)

1:00 PM Challenges and Opportunities in the Patient's Pathway to Access - Menia Koukougianni (NGO KARKINAKI)

1:20 PM Empowering patient advocacy and cancer prevention - Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)

1:35 PM Concluding remarks - Sandro Rossi (CNAO)
3:00 PM SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
3:00 PM - 6:45 PM
Contributions

3:00 PM Carbon Programme in MedAustron - Piero Fossati (MedAustron)

3:15 PM Pediatric Treatments in MedAustron - Carola Lütgendorf-Caucig (MedAustron)

3:30 PM Hadron therapy state-of-the art in pediatric oncology-clinical aspects - Sabina Vennarini (CNAO)

3:45 PM Treatment planning for pediatric cancer tumour treatments - Alfredo Mirandola (CNAO)

4:00 PM Pediatric brain tumour surgery : where do we stand? - Nikos Foroglou (AUTH/AHEPA)

4:15 PM Role of surgery in pediatric soft tissue sarcoma - Aikaterini Tzantzaroudi (Hippokration Hospital)

5:00 PM Panel discussion: Paediatric Oncology in Greece

5:01 PM Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA - Emmanouel Chatzipantelis (AUTH/AHEPA)

5:15 PM Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital - Evgenia Papakonstantinou (Hippokrateio Hospital)

5:30 PM Pediatric patients commonly referred for external beam Radiotherapy - Antonio Capizzello (AUTH / AHEPA) Eftychia Tataridou (Theageneio Hospital)

5:45 PM The spectrum of pediatric patients referred for Protontherapy - Barbara Rombi (APSS - TRENTO)

6:00 PM Radiation treatment plan for pediatric cancer: a clinical view - George Giakoumetis (AUTH/AHEPA)

6:15 PM Concluding remarks - Semi Harrabi (HIT)

Choose timezone